Efficacy of QAX576 in Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Asthma
Interventions
BIOLOGICAL

QAX576

every 3 weeks via intravenous infusion

DRUG

Placebo

every 3 weeks via intravenous infusion

Trial Locations (52)

1020

Novartis Investigative Site, Laken

1070

Novartis Investigative Site, Brussels

3000

Novartis Investigative Site, Leuven

4000

Novartis Investigative Site, Liège

4700

Novartis Investigative Site, Eupen

9000

Novartis Investigative Site, Ghent

10117

Novartis Investigative Site, Berlin

14050

Novartis Investigative Site, Berlin

15562

Novartis Investigative Site, Rüdersdorf

20902

Novartis Investigative Site, Wheaton

22947

Novartis Investigative Site, Großhansdorf

29407

Novartis Investigative Site, Charleston

29485

Novartis Investigative Site, Summerville

34121

Novartis Investigative Site, Kassel

38601

Novartis Investigative Site, Strakonice

42301

Novartis Investigative Site, Owensboro

43302

Novartis Investigative Site, Marion

55131

Novartis Investigative Site, Mainz

55402

Novartis Investigative Site, Minneapolis

60596

Novartis Investigative Site, Frankfurt

63141

Novartis Investigative Site, St Louis

85006

Novartis Investigative Site, Phoenix

89119

Novartis Investigative Site, Las Vegas

92647

Novartis Investigative Site, Huntington Beach

105077

Novartis Investigative Site, Moscow

115280

Novartis Investigative Site, Moscow

150003

Novartis Investigative Site, Yaroslavl

390026

Novartis Investigative Site, Ryazan

420015

Novartis Investigative Site, Kazan'

443079

Novartis Investigative Site, Samara

603018

Novartis Investigative Site, Nizhny Novgorod

656045

Novartis Investigative Site, Barnaul

B8000XAV

Novartis Investigative Site, CABA

C1122AAK

Novartis Investigative Site, CABA

C1186ACB

Novartis Investigative Site, CABA

S2000CXH

Novartis Investigative Site, Rosario

S2000DBS

Novartis Investigative Site, Rosario

S2000DSV

Novartis Investigative Site, Rosario

S2000JKR

Novartis Investigative Site, Rosario

C1125ABE

Novartis Investigative Site, Buenos Aires

M5500FIK

Novartis Investigative Site, Mendoza

S3000FIL

Novartis Investigative Site, Santa Fe

337 01

Novartis Investigative Site, Rokycany

415 01

Novartis Investigative Site, Teplice

390 01

Novartis Investigative Site, Tábor

04207

Novartis Investigative Site, Leipzig

04357

Novartis Investigative Site, Leipzig

15-010

Novartis Investigative Site, Bialystok

80-211

Novartis Investigative Site, Gdansk

90-153

Novartis Investigative Site, Lodz

20-89

Novartis Investigative Site, Lublin

60-569

Novartis Investigative Site, Poznan

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY